Background
Case presentations
Patient 1
Age, year (y) month (m) | Suspected diagnoses | Methods | |
---|---|---|---|
Patient 1 | 0 y 9 m | Hypercortisolism | Cortisol profile and dexamethasone suppression test |
Hypothyroidism | Thyrotropin-releasing hormone stimulation test | ||
Growth hormone deficiency | Insulin hypoglycaemia test and radiography | ||
Brain tumour/brain malformation | Sonography | ||
1 y 10 m | Prader-Willi syndrome | MS-MLPA | |
Chromosome aberrations | Chromosome analysis | ||
Congenital leptin deficiency | Leptin ELISA | ||
2 y 6 m | Brain tumour/brain malformation | MRI | |
Pituitary tumour | MRI | ||
Hypercortisolism | Urinary cortisol profile | ||
Disorder of the adipocyte differentiation | In vitro functional examination | ||
Adrenal insufficiency | Adrenocorticotropic hormone test | ||
Adrenal gland tumour | CT | ||
Congenital leptin deficiency | Leptin ELISA | ||
Prohormone convertase deficiency | Oral glucose tolerance test, proinsulin ELISA | ||
Patient 2 | 1 y 11 m | Hypercortisolism | Cortisol profile |
Hypothyroidism | Laboratory | ||
Chromosome aberrations | Chromosome analysis | ||
Insulinoma | Blood glucose profile | ||
Prader-Willi syndrome | MS-MLPA | ||
Pseudohypoparathyroidism | Laboratory values and radiography | ||
Brain tumour/brain malformation | CT | ||
Glycogenosis type I | Clinical examinations | ||
2 y 9 m | Brain tumour/brain malformation | MRI | |
Hypothalamus tumour | MRI | ||
Prader-Willi syndrome | MS-MLPA | ||
5 y 6 m | Eating disorders | Psychological examinations | |
8 y 11 m | Growth hormone deficiency | l-Arginine and insulin-tolerance tests | |
9 y 3 m | Anterior pituitary insufficiency | Corticotropin-releasing hormone stimulation test and thyrotropin-releasing hormone stimulation test | |
Brain tumour/brain malformation | MRI | ||
11 y 9 m | Pituitary tumour | MRI | |
12 y 2 m | Disorder of the hypothalamic-pituitary-adrenal axis | Combined pituitary stimulation test | |
Adrenal insufficiency | Adrenocorticotropin stimulation test |
Age, year (y) month (m) | Measures for treatment of obesity | Impact on weight | |
---|---|---|---|
Patient 1 | Ongoing | Restrictive food intake and motivation for physical activity | None |
0 y 9 m | 9 days stay in a paediatric clinic with caloric restriction to 600 kcal per daya | None | |
3 y | 21 days stay in a specialised clinic for metabolic disorders and Prader-Willi syndromeb | None | |
4 y 2 m | 14 days stay in a specialised clinic for Tomatis Listening Therapyc | None | |
10 y 4 m | 2 years outpatient psychotherapy for mother and child | None | |
11 y 5 m | 6 weeks stay in a rehabilitation clinic focusing obesityd | − 10.7 kg (− 9.86%), followed by weight regain | |
14 y 7 m | 6 months stay in a rehabilitation clinic with obesity long-term therapye | − 15.6 kg (− 6.41%), followed by 9.3 kg weight regain within 1 month | |
18 y 1 m | Leaving the parental home and moving into an assisted living community | − 8 kg (+ 4.26%) | |
18 y 3 m | 2 years outpatient psychotherapy | None | |
18 y 4 m | Bariatric surgery: sleeve gastrectomyf | − 38 kg (− 20.13%), followed by weight regain (overall weight reduction, 16 kg (− 8.47%)) | |
Patient 2 | Ongoing | Restrictive food intake and motivation for physical activity | None |
1 y 11 m | 15 days stay in a paediatric clinic with daily 800 kcal caloric restrictiona | None | |
2 y 9 m | 7 weeks stay in a paediatric clinic with daily 400 kcal caloric restrictionb | − 4 kg (− 12.05%) | |
3 y 10 m | 1.5 years outpatient psychotherapy | None | |
5 y 6 m | 1 year inpatient psychotherapyc | − 14 kg (− 29.79%), followed by slow weight regain | |
6 y 5 m | 3 years outpatient psychotherapy | None | |
9 y 5 m | 3 years growth hormone treatment due to short stature and growth hormone deficiency | + 59 kg (+ 38.8%) | |
12 y 7 m | 4 months stay in a rehabilitation clinic with obesity long-term therapyd | + 4 kg (+ 4.0%) | |
12 y 11 m | Regular advice and support from the youth welfare department, psychological care and medical weight control | None | |
14 y 3 m | Bariatric surgery: gastric bandinge | − 49 kg (− 33.84%) | |
14 y 4 m | 28 days stay in a child and adolescent psychiatry after gastric banding | − 5 kg (− 3.72%) | |
25 y 0 m | Removal of gastric banding due to band migrationf | + 15 kg (+ 14.8%) within 4 years |
Patient 2
Findings
Patient 1 | Patient 2 | Reference range | ||
---|---|---|---|---|
Age | 20 years | 29 years | ||
Weight | kg | 172 | 120.5 | |
Height | m | 1.66 | 1.70 | |
BMI | kg/m2 | 62.1 | 41.6 | |
BMI SDS | 3.64 | 3.07 | ||
Blood pressure | mmHG | 121/85 | 137/86 | |
Pubertal stage by Tanner | PH, 5; B, 5 | PH, 6; testicular volume, 16 ml and 14 ml | ||
Insulin-like growth factor 1 | ng/ml | 231 | 182 | f, 122–384; m, 117–321 |
Leptin | μg/l | 34.4 | 12.5 | 3.6–11.1 |
Total cholesterol | mmol/l | 4.3 | 3.8 | < 5.0 |
LDL cholesterol | mmol/l | 3.2 | 2.3 | > 1.0 |
HDL cholesterol | mmol/l | 0.5 | 1.2 | < 3.0 |
Thyreotropin | MIU/l | 2.02 | 1.88 | 12.8–20.4 |
Free thyroxine | pmol/l | 11.7 | 19 | 3.13–6.76 |
Testosterone | μg/l | 0.19 | 4.25 | f, 0.084–0.481; m, 2.490–8.360 |